• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从疯牛病到合理输血:英国和法国中不稳定血液成分传播朊病毒的风险

From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France.

作者信息

Lefrère Jean-Jacques, Hewitt Patricia

机构信息

National Institute of Blood Transfusion, Paris, France.

出版信息

Transfusion. 2009 Apr;49(4):797-812. doi: 10.1111/j.1537-2995.2008.02044.x. Epub 2009 Jan 2.

DOI:10.1111/j.1537-2995.2008.02044.x
PMID:19170997
Abstract

Transfusion transmission of the prion, the agent of variant Creutzfeldt-Jakob disease (vCJD), is now established. Subjects infected through food may transmit the disease through blood donations. The two nations most affected to date by this threat are the United Kingdom (UK) and France. The first transfusion cases have been observed in the UK over the past 5 years. In France, a few individuals who developed vCJD had a history of blood donation, leading to a risk of transmission to recipients, some of whom could be incubating the disease. In the absence of a large-scale screening test, it is impossible to establish the prevalence of infection in the blood donor population and transfused patients. This lack of a test also prevents specific screening of blood donations. Thus, prevention of transfusion transmission essentially relies at present on deferral of "at-risk" individuals. Because prions are present in both white blood cells and plasma, leukoreduction is probably insufficient to totally eliminate the transfusion risk. In the absence of a screening test for blood donations, recently developed prion-specific filters could be a solution. Furthermore, while the dietary spread of vCJD seems efficiently controlled, uncertainty remains as to the extent of the spread of prions through blood transfusion and other secondary routes.

摘要

现已证实,变异型克雅氏病(vCJD)的病原体朊病毒可通过输血传播。通过食物感染的个体可能会通过献血传播该疾病。迄今为止,受这一威胁影响最大的两个国家是英国和法国。过去5年里,英国已发现首例输血感染病例。在法国,一些患上vCJD的人有过献血史,这就导致了将疾病传播给受血者的风险,其中一些受血者可能正处于疾病潜伏期。由于缺乏大规模筛查检测,无法确定献血人群和输血患者中的感染率。这种检测手段的缺失也使得无法对献血进行针对性筛查。因此,目前预防输血传播主要依靠推迟“高危”个体献血。由于朊病毒存在于白细胞和血浆中,白细胞滤除可能不足以完全消除输血风险。在缺乏献血筛查检测的情况下,最近研发的朊病毒特异性过滤器可能是一种解决办法。此外,虽然vCJD通过饮食传播似乎已得到有效控制,但朊病毒通过输血及其他次要途径传播的范围仍存在不确定性。

相似文献

1
From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France.从疯牛病到合理输血:英国和法国中不稳定血液成分传播朊病毒的风险
Transfusion. 2009 Apr;49(4):797-812. doi: 10.1111/j.1537-2995.2008.02044.x. Epub 2009 Jan 2.
2
[The risk of prion contamination through the transfusion of cellular products].[通过细胞制品输血感染朊病毒的风险]
Transfus Clin Biol. 2007 May;14(1):25-34. doi: 10.1016/j.tracli.2007.04.007. Epub 2007 May 11.
3
Evaluation of the protection of primates transfused with variant Creutzfeldt-Jakob disease-infected blood products filtered with prion removal devices: a 5-year update.用朊病毒去除装置过滤的变异型克雅氏病感染血液制品输注灵长类动物后的保护作用评估:5年更新情况
Transfusion. 2015 Jun;55(6):1231-41. doi: 10.1111/trf.12999. Epub 2015 Feb 3.
4
Universal white blood cell reduction in Europe: has transmission of variant Creutzfeldt-Jakob disease been prevented?欧洲普遍的白细胞减少症:变异型克雅氏病的传播是否已被阻止?
Transfus Med Rev. 2011 Apr;25(2):133-44. doi: 10.1016/j.tmrv.2010.11.005. Epub 2011 Feb 23.
5
Risks of transmission of variant Creutzfeldt-Jakob disease by blood transfusion.通过输血传播变异型克雅氏病的风险。
Folia Neuropathol. 2005;43(4):271-8.
6
All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD.所有具有临床相关性的血液成分在单次输血后都会传播朊病毒病:vCJD 的绵羊模型。
PLoS One. 2011;6(8):e23169. doi: 10.1371/journal.pone.0023169. Epub 2011 Aug 17.
7
Variant Creutzfeldt-Jakob disease transmission by plasma products: assessing and communicating risk in an era of scientific uncertainty.通过血浆制品传播变异型克雅氏病:在科学不确定性时代评估和传达风险
Vox Sang. 2005 Nov;89(4):186-92. doi: 10.1111/j.1423-0410.2005.00702.x.
8
Variant Creutzfeldt-Jakob disease.变异型克雅氏病
Lancet. 1999 Jul 24;354(9175):317-23. doi: 10.1016/S0140-6736(99)05128-4.
9
Preclinical transmission of prions by blood transfusion is influenced by donor genotype and route of infection.经输血传播的朊病毒的临床前传播受供体基因型和感染途径的影响。
PLoS Pathog. 2021 Feb 18;17(2):e1009276. doi: 10.1371/journal.ppat.1009276. eCollection 2021 Feb.
10
Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal.
Transfus Clin Biol. 2007 May;14(1):51-62. doi: 10.1016/j.tracli.2007.04.008. Epub 2007 May 30.

引用本文的文献

1
Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients.变异性克雅氏病和散发型克雅氏病患者外周组织中朊病毒感染性的广泛分布。
Acta Neuropathol. 2021 Mar;141(3):383-397. doi: 10.1007/s00401-021-02270-x. Epub 2021 Feb 2.
2
Propagated protein misfolding: New opportunities for therapeutics, new public health risk.传播性蛋白质错误折叠:治疗的新机遇,新的公共卫生风险。
Can Commun Dis Rep. 2015 Aug 6;41(8):196-199. doi: 10.14745/ccdr.v41i08a03.
3
Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic Patients.
变异型克雅氏病朊病毒在临床患者和无症状患者组织中的分布及定量评估
Emerg Infect Dis. 2017 Jun;23(6):946-956. doi: 10.3201/eid2306.161734.
4
Mononucleated Blood Cell Populations Display Different Abilities To Transmit Prion Disease by the Transfusion Route.单核血细胞群体通过输血途径传播朊病毒病的能力不同。
J Virol. 2016 Jan 13;90(7):3439-45. doi: 10.1128/JVI.02783-15.
5
Magnetic microparticle-based multimer detection system for the detection of prion oligomers in sheep.用于检测绵羊朊病毒寡聚体的基于磁性微粒的多聚体检测系统。
Int J Nanomedicine. 2015 Sep 9;10(Spec Iss):241-50. doi: 10.2147/IJN.S88377. eCollection 2015.
6
Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion.用于体外干细胞扩增的人血小板裂解物补充剂的制备、质量标准和特性
N Biotechnol. 2015 Jan 25;32(1):199-211. doi: 10.1016/j.nbt.2014.06.001. Epub 2014 Jun 11.
7
Prion diseases as transmissible zoonotic diseases.朊病毒病作为可传播的人畜共患病。
Osong Public Health Res Perspect. 2013 Feb;4(1):57-66. doi: 10.1016/j.phrp.2012.12.008.
8
The toll-like receptor agonist imiquimod is active against prions. Toll 样受体激动剂咪喹莫特对朊病毒有活性。
PLoS One. 2013 Aug 16;8(8):e72112. doi: 10.1371/journal.pone.0072112. eCollection 2013.
9
Revaluing donor and recipient bodies in the globalised blood economy: transitions in public policy on blood safety in the United Kingdom.在全球化的血液经济中重新评估供体和受体:英国血液安全公共政策的转变。
Health (London). 2014 Jan;18(1):79-94. doi: 10.1177/1363459313476966. Epub 2013 Mar 6.
10
Impact of leucocyte depletion and prion reduction filters on TSE blood borne transmission.白细胞去除和朊病毒减少过滤器对 TSE 血源传播的影响。
PLoS One. 2012;7(7):e42019. doi: 10.1371/journal.pone.0042019. Epub 2012 Jul 31.